Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALITRETINOIN for Kaposi's sarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where ALITRETINOIN was used for Kaposi's sarcoma.

Most Reported Side Effects for ALITRETINOIN

Side Effect Reports % Deaths Hosp.
Drug ineffective 20 25.0% 0 0
Breast cancer 14 17.5% 0 0
Drug intolerance 12 15.0% 0 0
Off label use 12 15.0% 0 1
Pruritus 12 15.0% 0 0
Hepatic enzyme increased 11 13.8% 0 0
Blister 9 11.3% 0 0
Pain in extremity 9 11.3% 0 0
Psoriatic arthropathy 9 11.3% 0 0
Skin injury 9 11.3% 0 0
Abdominal discomfort 8 10.0% 0 0
Treatment failure 8 10.0% 0 0
C-reactive protein increased 7 8.8% 0 0
Hypercholesterolaemia 7 8.8% 0 1
Xerophthalmia 7 8.8% 0 0

Other Indications for ALITRETINOIN

Product used for unknown indication (20) Pityriasis rubra pilaris (14) Neurodermatitis (11) Pustular psoriasis (9) Psoriasis (6)

Other Drugs Used for Kaposi's sarcoma

POMALIDOMIDE (268) DOXORUBICIN (238) PACLITAXEL (122) VINCRISTINE (78) BLEOMYCIN (58) LENALIDOMIDE (54) ETOPOSIDE (38) RITUXIMAB (27) PREDNISONE (23) GEMCITABINE (21)

Related Pages

ALITRETINOIN Full Profile All Kaposi's sarcoma Drugs ALITRETINOIN Demographics ALITRETINOIN Timeline